While our Boston office provides key strategy inputs in adaptive and bayesian trial designs and strategic and regulatory consulting services, our Indian offices provide Programming, Biostatistics and AI/ML algorithm development and Scientific Writing services"
WALTHAM, Mass. (PRWEB) March 02, 2020
Genpro Research announces expansion of their India operations with the strategic establishment of a new office in Baroda, Gujarat. Genpro Baroda center will focus on Medical Writing and Scientific Communications in addition to Biostatistics, Programming, Clinical Data Management, and Strategic consulting services for global pharmaceutical, biotechnology, and medical device companies. As part of this expansion, Dr Kapil Khambholja has joined Genpro Research as a co-founder and Vice President of Medical Writing services.
Dr. Kapil brings in 15+ years of preclinical and clinical research experience through his varied roles with academia, global pharmaceutical companies, and leading CROs. He will be responsible for expanding Medical & Scientific Writing services for global and local clients while providing strategic inputs for the innovative AI/ML based platforms that Genpro has developed to accelerate drug research. He will also work closely to integrate line functions and leverage the use of RWE & HEOR offerings for our customers. This expansion will help Genpro to provide integrated end-to-end service offerings for the drug and device development pipeline.
“We are extremely excited to welcome Dr. Kapil Khambholja to Genpro Research. We have been following a strategy wherein specific offshore centers will develop capabilities in core functions. While our Boston office provides key strategy inputs in adaptive and bayesian trial designs and strategic and regulatory consulting services, our Indian offices provide SAS Programming, Biostatistics and AI/ML algorithm development. The key function of the Baroda center will be to provide Scientific Writing services and also explore methods to automate the medical writing, HEOR and RWD functions using the digital frameworks that we have developed”, said Anoop P Ambika, Chief Executive Officer of Genpro Research.
Genpro currently employs close to 100 professionals across the 5 global centers of excellence.
Genpro Research is a next-generation services and technology partner for the pharmaceutical, biotechnology, and medical devices industry. Our tools use Artificial Intelligence, Machine Learning, and Natural Language Processing algorithms to enable automation of several processes in a drug development pipeline. We provide advanced solutions in Biostatistics & Programming, Medical Writing, and Regulatory Submissions.
Genpro currently has a US office in Waltham, MA. We have offshore development centers in four cities in India - Thiruvananthapuram, Kochi, Baroda and Bangalore. Genpro also offers two digital platforms; Voody for Structured Literature Review and MOSS for Clinical Data Visualisation and Analytics.